vildagliptin/metformin stada 50mg/850mg potahovaná tableta
stada arzneimittel ag, bad vilbel array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a vildagliptin
vildagliptin/metformin teva 50mg/1000mg potahovaná tableta
teva b.v., haarlem array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a vildagliptin
vildagliptin/metformin teva 50mg/850mg potahovaná tableta
teva b.v., haarlem array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a vildagliptin
sitagliptin/metformin +pharma 50mg/1000mg potahovaná tableta
+pharma arzneimittel gmbh, graz array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a sitagliptin
sitagliptin/metformin +pharma 50mg/850mg potahovaná tableta
+pharma arzneimittel gmbh, graz array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a sitagliptin
metformin medreg 1000mg potahovaná tableta
medreg s.r.o., praha array - 2418 metformin-hydrochlorid - potahovaná tableta - 1000mg - metformin
metformin medreg 850mg potahovaná tableta
medreg s.r.o., praha array - 2418 metformin-hydrochlorid - potahovaná tableta - 850mg - metformin
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
zomarist
novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - léky užívané při diabetu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
metformin medreg 500mg potahovaná tableta
medreg s.r.o., praha array - 2418 metformin-hydrochlorid - potahovaná tableta - 500mg - metformin